A cell adhesion inhibitor of the general formula: R3-L-L'-R1 is disclosed. An inhibitor of the present invention interacts with VLA-4 molecules and inhibits VLA-4 dependent cell adhesion. Also disclosed are methods for preparing and using such a cell adhesion inhibitor, as well as pharmaceutical compositions containing the same.
DUBEY, S. K.;KNAUS, E. E., CAN. J. CHEM., 1983, 61, N 3, 565-572
作者:DUBEY, S. K.、KNAUS, E. E.
DOI:——
日期:——
[EN] THIAZOLOPYRIDINE DERIVATIVES AS GPR119 AGONISTS<br/>[FR] DÉRIVÉS DE LA THIAZOLOPYRIDINE EN TANT QU'AGONISTES DU RÉCEPTEUR GPR119
申请人:MANKIND PHARMA LTD
公开号:WO2017175068A1
公开(公告)日:2017-10-12
The present invention relates to novel compounds of formula (I) as GPR119 agonist, composition compositions containing such compounds and method of preparation thereof.
Stereospecific vicinal oxyamination of <i>N</i>-substituted 1,2,3,6-tetrahydropyridines and 1,2-dihydropyridines by <i>N</i>-chloro-<i>N</i>-metallocarbamates
作者:Sushil K. Dubey、Edward E. K. Naus
DOI:10.1139/v83-100
日期:1983.3.1
The vicinaloxyamination of 1-substituted 1,2,3,6-tetrahydropyridines (2) affords a mixture of the regioisomeric cis-hydroxycarbamates 3 and 4. The tert-butoxycarbonylamino and hydroxyl substituent...
Structural features, chemical stabilities and catalytic profiles in olefin metathesis of a new library of low-cost cycloalkyl-based U2-NHC Ru complexes were disclosed.